KukoaMine B

CAS No. 164991-67-7

KukoaMine B( —— )

Catalog No. M20169 CAS No. 164991-67-7

Kukoamine B is a component of Lycii Cortex with anti-oxidant anti-acute inflammatory and anti-diabetic properties.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 77 In Stock
10MG 123 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    KukoaMine B
  • Note
    Research use only, not for human use.
  • Brief Description
    Kukoamine B is a component of Lycii Cortex with anti-oxidant anti-acute inflammatory and anti-diabetic properties.
  • Description
    Kukoamine B is a component of Lycii Cortex with anti-oxidant anti-acute inflammatory and anti-diabetic properties.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Antioxidant
  • Recptor
    Antioxidant
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    164991-67-7
  • Formula Weight
    530.66
  • Molecular Formula
    C28H42N4O6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:30 mg/mL (56.53mM)
  • SMILES
    NCCCN(CCCCNCCCNC(=O)CCc1ccc(O)c(O)c1)C(=O)CCc1ccc(O)c(O)c1
  • Chemical Name
    N-(3-aminopropyl)-3-(34-dihydroxyphenyl)-N-(4-((3-(3-(34-dihydroxyphenyl)propanamido)propyl)amino)butyl)propanamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kukoamine B a novel dual?inhibitor?of LPS and CpG DNA is a potential candidate for sepsis treatment
molnova catalog
related products
  • Methyl-β-cyclodextri...

    Methyl-β-cyclodextrin, a cyclic heptasaccharide, is an effective agent for the depletion of cholesterol from cells; also inhibits PEL cell growth with an IC50 of 3.33-4.23 mM.

  • Notoginsenoside R2

    Notoginsenoside R2 has neuroprotection against 6-OHDA-induced neurotoxicity, is associated with Notoginsenoside R2-mediated P90RSK and Nrf2 activation through MEK1/2-ERK1/2 pathways.

  • Succinylcholine Chlo...

    Succinylcholine Chloride Dihydrate is a nicotinic AChR agonist and also acts as a depolarizing neuromuscular blocker.